Joint Corp. To Close Underperforming Clinics In 2026

Aug. 7 (Reuters) - Joint Corp. (NYSE American: JYNT):

• Joint outlook FY adjusted EBITDA: $12.5 million-$13.5 million
• Joint Q2 revenue: $15.2 million, versus the IBES estimate of $14.6 million
• Joint Corp.: total clinic count was 941 at June 30, 2026
• Joint Corp. said it will close underperforming clinics in 2026; clinic count at 2026 year-end is expected to be lower than 2025 year-end
• Joint Corp.: 2026 new franchised clinic openings expected to be 22-26